| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2f399dc19ecdf6dde7928fc38221309
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d41cb7fd4454f1f366d7d3f669db340
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9b83d53426d0a3dfbb69a8826ec116d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-08 |
| filingDate |
1987-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_579d0eebf5e5af818c892d65f435e932
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0497321abd29d2dfdee761c74bf10640
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0478911f749cdde9ebeb76840c9009eb |
| publicationDate |
1988-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-8800051-A1 |
| titleOfInvention |
Proceeding for the production of pharmaceutical preparations of high gastric acid binding capacity, of retarded effect and of increased bioavailability |
| abstract |
Production of a new pharmaceutical preparation of high acid-binding capacity, of retarded effect, of increased bioavailability forneutralization of gastric acid and eventually to other pharmaceutical preparations acting in the gastrointestinal tract, first of all of laxative effect by mixing 100 parts by mass of a powdered basic magnesium compound or the powdered mixture of basic magnesium compounds and basic aluminium compounds with 2-2500 parts of a dry or in water swollen organic acid of polymeric character and therapeutically acceptable, e. g. cellulose-glycolic acid, starch-glycolic acid or polymer acrylic and/or methacrylic acid, letting this powdered mixture to stand for 1-24 hours at the temperature of 20-80C after addition of 50-500 parts by mass of water and forming tablets or other pharmaceutical preparations, eventually after addition of 5-60 parts by mass of smoothing agents and/or other pharmaceutical excipients, or tansforming the mixture containing the basic active ingredients and the polymeric organic acid in liquid suspension by adding water and eventually excipients. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0486863-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5288506-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9421268-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5213794-A |
| priorityDate |
1986-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |